Anacor Pharmaceuticals Adds $25 Million in Funding

Dermatology pharmaceutical developer Anacor Pharmaceuticals says it's raised $25 million in a third round of financing. The Palo Alto company says the financing was co-led by Care Capital and Venrock Associates. Other new investors included Red Abbey Venture Partners and individuals associated with the company. Existing investors Aberdare Ventures and Rho Ventures also participated in the round.

Silicon Valley/San Jose Business Journal (http://www.bizjournals.com/sanjose/stories/2005/05/09/daily28.html)